Viewing StudyNCT01624532



Ignite Creation Date: 2024-05-06 @ 12:39 AM
Last Modification Date: 2024-10-26 @ 10:52 AM
Study NCT ID: NCT01624532
Status: COMPLETED
Last Update Posted: 2023-01-04
First Post: 2012-03-06

Brief Title: A Study to Assess Dose-Response Efficacy Immunogenicity and the Safety of GC1109
Sponsor: Green Cross Corporation
Organization: GC Biopharma Corp

Key Dates - Follows AllAPIJSON File Order

Start Date: 2021-07-14
Start Date Type: ACTUAL
Primary Completion Date: 2022-08-02
Primary Completion Date Type: ACTUAL
Completion Date: 2022-12-19
Completion Date Type: ACTUAL
First Submit Date: 2012-03-06
First Submit QC Date: June 19 2012
Study First Post Date: 2012-06-20
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2023-01-02
Last Update Post Date: 2023-01-04
Last Update Post Date Type: ACTUAL